NeoAdjuvant, Spare-Adjuvant (NASA) in Stage IIIB-IV (M1a) Melanoma

NCT07740941 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

55

Enrollment

OTHER

Sponsor class

Conditions

Melanoma (Skin Cancer)
Melanoma Stage Stage IIIB
Melanoma Stage M1
Melanoma Stage IV

Interventions

DRUG: Pembrolizumab
DRUG: Ipilimumab plus nivolumab

Sponsor

UNC Lineberger Comprehensive Cancer Center